Evidence map›Paper›PMID 31571667›Full record

ArticleNeural regeneration research2020

Neuroprotection of

Si-Qun Jing, Sai-Sai Wang, Rui-Min Zhong, Jun-Yan Zhang, Jin-Zi Wu, Yi-Xian Tu, Yan Pu, Liang-Jun Yan

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. A PET Fluorescent Probe for Dynamic PdMolecules (Basel, Switzerland) · 2023
    Article
  13. Cardioprotective effects of sinomenine in myocardial ischemia/reperfusion injury in a rat model.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  14. Cyperus (Plants (Basel, Switzerland) · 2022
    Review
  15. Article
  16. Article
  17. Orientin Prolongs the Longevity ofOxidative medicine and cellular longevity · 2022
    Article
  18. Oxidative medicine and cellular longevity · 2021
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Si-Qun JingYingdong College of Food Science and Engineering, Shaoguan University, Shaoguan, Guangdong Province, China.
Sai-Sai WangSchool of Bioengineering, Jiangnan University, Wuxi, Jiangsu Province, China.
Rui-Min ZhongYingdong College of Food Science and Engineering, Shaoguan University, Shaoguan, Guangdong Province, China.
Jun-Yan ZhangYingdong College of Food Science and Engineering, Shaoguan University, Shaoguan, Guangdong Province, China.
Jin-Zi WuDepartment of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA.
Yi-Xian TuCollege of Life Sciences and Technology, Xinjiang University, Urumqi, Xinjiang Uygur Autonomous Region, China.
Yan PuCollege of Life Sciences and Technology, Xinjiang University, Urumqi, Xinjiang Uygur Autonomous Region, China.
Liang-Jun YanDepartment of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA.
Shaoguan University · CNXinjiang University · CNJiangnan University · CNUniversity of North Texas · USUniversity of North Texas System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orientin is a flavonoid monomer. In recent years, its importance as a source of pharmacological active substance is growing rapidly due to its properties such as anti-myocardial ischemia, anti-apoptosis, anti-radiation, anti-tumor, and anti-aging. However, the neuroprotective effects of Orientin on stroke injury have not been comprehensively evaluated. The aim of the present study was thus to investigate the neuroprotective capacity and the potential mechanisms of Cyperus esculentus L. orientin (CLO) from Cyperus esculentus L. leaves against ischemia/reperfusion (I/R) injury using standard orientin as control. For in vitro studies, we treated HT22 cells with CoCl

Indexed as

antioxidantscaspase-3cerebral ischemia/reperfusion injurycobalt chlorideCyperus esculentus L. orientin (CLO)lipid peroxidationnerve regenerationneurological deficitsoxidative stressreactive oxygen species

Identifiers

PMID31571667
PMCPMC6921342
OpenAlexW2975923821

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.